The study suggests that the price of patented medicine in Thailand should be controlled based on equity pricing and outcome pricing. Equity pricing can be estimated from the international reference price and outcome pricing can be evaluated from therapeutic referencing or the pharmacoeconomic price. Moreover, in a case study of 7 medicines granted

Patients with Down’s syndrome have developmental delay and abnormalities in their biological system. Most of the patients cannot take care of themselves. They must have long term treatment which is quite expensive. Currently there is no curative therapy for Down’s syndrome. Screening and prenatal diagnosis to detect abnormalities of Down’s sy

1. BackgroundSince 2011 the Ministry of Public Health (MOPH) and the National Health Security Office (NHSO) has collaborated in health promotion and disease prevention program, which aims to provide a high quality of health promotion and disease prevention services for all Thai people. Although the NHSO has indicators for health promotion and disea

Project Consultant Dr. Yot Teerawattananon and Dr. Wanrudee Isaranuwatchai      63191002RM018L0quarantine guideline

The objective of this study is to estimate the cost-utility analysis of the cholinesterase inhibitors (i.e., donepezil, galantamine and rivastigmine) compared with no drug treatment in patients with mild to moderate alzheimer’s disease (AD) in Thailand based on the societal and governmental perspectives and to estimate the budget impact of the ch

This cost-utility analysis was conducted as the result of a request from the Subcommittee for Development of the NLEM to provide information on the long-term effectiveness and cost-effectiveness of the screening of osteoporosis and its medical management. This information was then used to inform the Subcommittee regarding the selection of osteoporo

May 8 – 10, 2024 – the Ministry of Public Health, by the Health Intervention Technology Assessment Thailand (HITAP), partnered with the International Society for Priorities in Health (ISPH), a network of researchers, medical professionals, and policy-makers working in health prioritization, to organ

Traditional and complementary medicines (T&CM) have increased in uptake and economic importance globally. T&CM involves the examination, diagnosis, therapy, treatment, disease prevention, and rehabilitation. The World Health Organization's (WHO) Traditional Medicine Strategy 2014-2023 outlin

The report summarises a visit to Tanzania and has been prepared by Mr. Panupong Chaowanasawat and Dr. Brandon Chua from the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. The study visit was supported by the Access and Delivery Partnership (ADP), led by the Unite